Literature DB >> 7914890

Glycosylation and phosphorylation of arylsulfatase A.

H J Sommerlade1, T Selmer, A Ingendoh, V Gieselmann, K von Figura, K Neifer, B Schmidt.   

Abstract

The glycosylation and phosphorylation of the lysosomal enzyme arylsulfatase A was analyzed by a combination of metabolic labeling, tryptic fragmentation, mass spectrometry, and radiosequencing. The results demonstrate that all three potential N-glycosylation sites at Asn residues 158, 184, and 350 are utilized in arylsufatase A and carry high mannose or hybride type oligosaccharides. Phosphorylation of mannose residues is restricted to oligosaccharides at the first and third N-glycosylation site (Asn-158 and Asn-350). Both are phosphorylated with comparable efficiency. An earlier study had shown that a mutant arylsulfatase A containing only the second N-glycosylation site at Asn-184 folds correctly and is phosphorylated (Gieselmann, V., Schmidt, B., and von Figura, K. (1992) J. Biol. Chem. 267, 13262-13266). The lack of phosphorylation at Asn-184 in wild type arylsulfatase A therefore indicates that in vivo the presence of oligosaccharides can interfere with phosphorylation of other sites or that phosphorylation occurs in an ordered manner whereby phosphorylation of one site can affect the phosphorylation of another site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914890

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Conversion of cysteine to formylglycine: a protein modification in the endoplasmic reticulum.

Authors:  T Dierks; B Schmidt; K von Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

2.  Sequence determinants directing conversion of cysteine to formylglycine in eukaryotic sulfatases.

Authors:  T Dierks; M R Lecca; P Schlotterhose; B Schmidt; K von Figura
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

3.  Phosphorylation of arylsulphatase A occurs through multiple interactions with the UDP-N-acetylglucosamine-1-phosphotransferase proximal and distal to its retrieval site by the KDEL receptor.

Authors:  F Dittmer; K von Figura
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

4.  Secretion of phosphomannosyl-deficient arylsulphatase A and cathepsin D from isolated human macrophages.

Authors:  Nicole Muschol; Ulrich Matzner; Stephan Tiede; Volkmar Gieselmann; Kurt Ullrich; Thomas Braulke
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

5.  Cell-surface arylsulfatase A and B on sinusoidal endothelial cells, hepatocytes, and Kupffer cells in mammalian livers.

Authors:  Keiko Mitsunaga-Nakatsubo; Shinichiro Kusunoki; Hayato Kawakami; Koji Akasaka; Yoshihiro Akimoto
Journal:  Med Mol Morphol       Date:  2009-06-18       Impact factor: 2.309

6.  Arylsulfatase A: relationship of genotype to variant electrophoretic properties.

Authors:  D S Park; R D Poretz; M H Ricketts; P Manowitz
Journal:  Biochem Genet       Date:  1996-04       Impact factor: 1.890

Review 7.  Glyco-engineering strategies for the development of therapeutic enzymes with improved efficacy for the treatment of lysosomal storage diseases.

Authors:  Doo-Byoung Oh
Journal:  BMB Rep       Date:  2015-08       Impact factor: 4.778

8.  Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.

Authors:  Vasco Meneghini; Giacomo Frati; Davide Sala; Silvia De Cicco; Marco Luciani; Chiara Cavazzin; Marianna Paulis; Wieslawa Mentzen; Francesco Morena; Serena Giannelli; Francesca Sanvito; Anna Villa; Alessandro Bulfone; Vania Broccoli; Sabata Martino; Angela Gritti
Journal:  Stem Cells Transl Med       Date:  2016-09-16       Impact factor: 6.940

Review 9.  Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches.

Authors:  Alisa A Shaimardanova; Daria S Chulpanova; Valeriya V Solovyeva; Aysilu I Mullagulova; Kristina V Kitaeva; Cinzia Allegrucci; Albert A Rizvanov
Journal:  Front Med (Lausanne)       Date:  2020-10-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.